Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,954 | 20,527 | 21,545 | 17,127 | -1,187 |
| Depreciation Amortization | 5 | 167 | 121 | 87 | 46 |
| Accounts receivable | 1,868 | -903 | 1,034 | -4,942 | 1,124 |
| Accounts payable and accrued liabilities | -174 | -2,096 | -2,487 | -2,094 | -2,565 |
| Other Working Capital | -960 | -5,795 | -4,106 | -8,864 | -2,788 |
| Other Operating Activity | -7,307 | -13,241 | -16,996 | -6,838 | 1,095 |
| Operating Cash Flow | $-1,614 | $-1,340 | $-890 | $-5,523 | $-4,274 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -59 | -15,102 | -15,031 | N/A | N/A |
| PPE Investments | -918 | -1,307 | -631 | -625 | -5 |
| Other Investing Activity | 0 | 3,100 | 3,100 | 3,100 | 0 |
| Investing Cash Flow | $-976 | $-13,309 | $-12,562 | $2,475 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 3,295 | 3,295 | 3,295 | 2,697 |
| Common Stock Repurchased | N/A | -125 | -125 | -125 | N/A |
| Dividend Paid | -8 | -30 | -23 | -15 | -8 |
| Financing Cash Flow | $-8 | $3,140 | $3,147 | $3,155 | $2,690 |
| Exchange Rate Effect | 35 | -8 | 1 | 24 | 18 |
| Beginning Cash Position | 10,114 | 21,631 | 21,631 | 21,631 | 21,631 |
| End Cash Position | 7,551 | 10,114 | 11,328 | 21,761 | 20,060 |
| Net Cash Flow | $-2,563 | $-11,517 | $-10,304 | $130 | $-1,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,614 | -1,340 | -890 | -5,523 | -4,274 |
| Capital Expenditure | -918 | -1,307 | -631 | -625 | -5 |
| Free Cash Flow | -2,531 | -2,647 | -1,521 | -6,149 | -4,279 |